Francisco Conesa Buendía

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

December, 2024

Francisco Conesa Buendía

Dec 16, 2024, 15:55 | Science

Francisco Conesa Buendía: Comprehensive Insights into CAR T-Cell Therapy Toxicities and Management Strategies

Francisco Conesa Buendía, Assistant, Cell and Gene Therapies Manufacturingat Memorial Sloan Kettering Cancer Center, shared…

Nov 7, 2024, 13:07 | Blog

Francisco Conesa Buendía: Advancing CAR-T Cell Therapy for Solid Tumors

Francisco Conesa Buendía, Assistant of Cell and Gene Therapies Manufacturing at Memorial Sloan Kettering Cancer…

Nov 4, 2024, 15:55 | Insight

Yan Leyfman: An innovative approach to promote CAR T cell longevity and boost therapeutic efficacy

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn by Francisco…

Oct 30, 2024, 13:33 | Blog

Francisco Conesa Buendía: How CRISPR is shaping the future of CAR T-cell therapy

Francisco Conesa Buendía, Cell and Gene Therapies Manufacturing Assistant at Memorial Sloan Kettering Cancer Center,…

All: 4 Posts: 1 - 100

'

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

'

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

'

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

'

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

'

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023